The recent accumulating evidence centered on the role of the Hippo pathway in hepatocyte proliferation and adult liver tumorigenesis has implicated YAP as a potential therapeutic target for the treatment of HCC. The gene discussed is YAP1; the disease is hepatocellular carcinoma.